Cargando…
TGFβ Controls Ovarian Cancer Cell Proliferation
There have been no major improvements in the overall survival of ovarian cancer patients in recent decades. Even though more accurate surgery and more effective treatments are available, the mortality rate remains high. Given the differences in origin and the heterogeneity of these tumors, research...
Autores principales: | Alsina-Sanchís, Elisenda, Figueras, Agnès, Lahiguera, Alvaro, Gil-Martín, Marta, Pardo, Beatriz, Piulats, Josep M., Martí, Lola, Ponce, Jordi, Matias-Guiu, Xavier, Vidal, August, Villanueva, Alberto, Viñals, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578048/ https://www.ncbi.nlm.nih.gov/pubmed/28758950 http://dx.doi.org/10.3390/ijms18081658 |
Ejemplares similares
-
Generation and Integrated Analysis of Advanced Patient‐Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer
por: Devis‐Jauregui, Laura, et al.
Publicado: (2022) -
Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
por: Juliachs, Mercè, et al.
Publicado: (2013) -
Characterization of the Endometrial MSC Marker Ectonucleoside Triphosphate Diphosphohydrolase-2 (NTPDase2/CD39L1) in Low- and High-Grade Endometrial Carcinomas: Loss of Stromal Expression in the Invasive Phenotypes
por: Rodríguez-Martínez, Aitor, et al.
Publicado: (2021) -
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors
por: Lahiguera, Álvaro, et al.
Publicado: (2020) -
The impact of KRAS mutations on VEGF-A production and tumour vascular network
por: Figueras, Agnès, et al.
Publicado: (2013)